-
1
-
-
33846691564
-
Iron uptake and metabolism in the new millennium
-
DOI 10.1016/j.tcb.2006.12.003, PII S0962892406003400
-
Dunn LL, Rahmanto YS, Richardson DR. Iron uptake and metabolism in the new millennium. Trends Cell Biol 2007; 17:93-100. (Pubitemid 46199183)
-
(2007)
Trends in Cell Biology
, vol.17
, Issue.2
, pp. 93-100
-
-
Dunn, L.L.1
Rahmanto, Y.S.2
Richardson, D.R.3
-
2
-
-
67849087296
-
Regulation of intestinal iron absorption: The mucosa takes control?
-
Simpson RJ, McKie AT. Regulation of intestinal iron absorption: the mucosa takes control? Cell Metab 2009;10:84-7.
-
(2009)
Cell Metab
, vol.10
, pp. 84-87
-
-
Simpson, R.J.1
McKie, A.T.2
-
3
-
-
58749094789
-
Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency
-
Shah YM, Matsubara T, Ito S, Yim SH, Gonzalez FJ. Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab 2009;9:152-64.
-
(2009)
Cell Metab
, vol.9
, pp. 152-164
-
-
Shah, Y.M.1
Matsubara, T.2
Ito, S.3
Yim, S.H.4
Gonzalez, F.J.5
-
4
-
-
66449124596
-
HIF-2 alpha, but not HIF-1 alpha, promotes iron absorption in mice
-
Mastrogiannaki M, Matak P, Keith B, Simon MC, Vaulont S, Peyssonnaux C. HIF-2 alpha, but not HIF-1 alpha, promotes iron absorption in mice. J Clin Invest 2009;119:1159-66.
-
(2009)
J Clin Invest
, vol.119
, pp. 1159-1166
-
-
Mastrogiannaki, M.1
Matak, P.2
Keith, B.3
Simon, M.C.4
Vaulont, S.5
Peyssonnaux, C.6
-
5
-
-
37449009448
-
Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum
-
Galy B, Ferring-Appel D, Kaden S, Gröne HJ, Hentze MW. Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum. Cell Metab 2008; 7:79-85.
-
(2008)
Cell Metab
, vol.7
, pp. 79-85
-
-
Galy, B.1
Ferring-Appel, D.2
Kaden, S.3
Gröne, H.J.4
Hentze, M.W.5
-
6
-
-
34247628002
-
Iron-regulatory proteins limit hypoxia-inducible factor-2alpha expression in iron deficiency
-
DOI 10.1038/nsmb1222, PII NSMB1222
-
Sanchez M, Galy B, Muckenthaler MU, Hentze MW. Iron-regulatory proteins limit hypoxia-inducible factor-2 alpha expression in iron deficiency. Nat Struct Mol Biol 2007;14:420-6. (Pubitemid 46685876)
-
(2007)
Nature Structural and Molecular Biology
, vol.14
, Issue.5
, pp. 420-426
-
-
Sanchez, M.1
Galy, B.2
Muckenthaler, M.U.3
Hentze, M.W.4
-
7
-
-
57849147670
-
Small-molecule inhibitors of HIF-2a translation link its 5?UTR iron-responsive element to oxygen sensing
-
Zimmer M, Ebert BL, Neil C, et al. Small-molecule inhibitors of HIF-2a translation link its 5?UTR iron-responsive element to oxygen sensing. Mol Cell 2008;32:838-48.
-
(2008)
Mol Cell
, vol.32
, pp. 838-848
-
-
Zimmer, M.1
Ebert, B.L.2
Neil, C.3
-
8
-
-
65349126484
-
A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression
-
Zhang DL, Hughes RM, Ollivierre- Wilson H, Ghosh MC, Rouault TA. A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab 2009;9:461-73.
-
(2009)
Cell Metab
, vol.9
, pp. 461-473
-
-
Zhang, D.L.1
Hughes, R.M.2
Ollivierre- Wilson, H.3
Ghosh, M.C.4
Rouault, T.A.5
-
9
-
-
10844258104
-
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
-
DOI 10.1126/science.1104742
-
Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306: 2090-3. (Pubitemid 40007660)
-
(2004)
Science
, vol.306
, Issue.5704
, pp. 2090-2093
-
-
Nemeth, E.1
Tuttle, M.S.2
Powelson, J.3
Vaughn, M.D.4
Donovan, A.5
Ward, D.M.6
Ganz, T.7
Kaplan, J.8
-
10
-
-
62649135982
-
Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2
-
De Domenico I, Lo E, Ward DM, Kaplan J. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2. Proc Natl Acad Sci U S A 2009;106:3800-5.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 3800-3805
-
-
De Domenico, I.1
Lo, E.2
Ward, D.M.3
Kaplan, J.4
-
11
-
-
82955241072
-
Non-transferrin bound iron: A key role in iron overload and iron toxicity
-
August 9 (Epub ahead of print)
-
Brissot P, Ropert M, Le Lan C, Loreal O. Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta 2011 August 9 (Epub ahead of print).
-
(2011)
Biochim Biophys Acta
-
-
Brissot, P.1
Ropert, M.2
Le Lan, C.3
Loreal, O.4
-
12
-
-
14544271816
-
LPI-labile plasma iron in iron overload
-
DOI 10.1016/j.beha.2004.10.003, PII S1521692604001264
-
Cabantchik ZI, Breuer W, Zanninelli G, Cianciulli P. LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol 2005;18:277-87. (Pubitemid 40298370)
-
(2005)
Best Practice and Research: Clinical Haematology
, vol.18
, Issue.2 SPEC. ISS.
, pp. 277-287
-
-
Cabantchik, Z.I.1
Breuer, W.2
Zanninelli, G.3
Cianciulli, P.4
-
13
-
-
0031028178
-
Tissue-specific regulation of iron metabolism and heme synthesis: Distinct control mechanisms in erythroid cells
-
Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 1997;89:1-25. (Pubitemid 26428173)
-
(1997)
Blood
, vol.89
, Issue.1
, pp. 1-25
-
-
Ponka, P.1
-
14
-
-
0023876497
-
Iron metabolism in the erythrophagocytosing Kupffer cell
-
Kondo H, Saito K, Grasso JP, Aisen P. Iron metabolism in the erythrophagocytosing Kupffer cell. Hepatology 1988;8: 32-8. (Pubitemid 18092055)
-
(1988)
Hepatology
, vol.8
, Issue.1
, pp. 32-38
-
-
Kondo, H.1
Saito, K.2
Grasso, J.P.3
Aisen, P.4
-
15
-
-
0030608152
-
The ferritins: Molecular properties, iron storage function and cellular regulation
-
DOI 10.1016/0005-2728(96)00022-9
-
Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996;1275:161-203. (Pubitemid 26248989)
-
(1996)
Biochimica et Biophysica Acta - Bioenergetics
, vol.1275
, Issue.3
, pp. 161-203
-
-
Harrison, P.M.1
Arosio, P.2
-
16
-
-
78650908746
-
Decoupling ferritin synthesis from free cytosolic iron results in ferritin secretion
-
De Domenico I, Vaughn MB, Paradkar PN, Lo E, Ward DM, Kaplan J. Decoupling ferritin synthesis from free cytosolic iron results in ferritin secretion. Cell Metab 2011;13:57-67.
-
(2011)
Cell Metab
, vol.13
, pp. 57-67
-
-
De Domenico, I.1
Vaughn, M.B.2
Paradkar, P.N.3
Lo, E.4
Ward, D.M.5
Kaplan, J.6
-
17
-
-
77953872577
-
Serum ferritin: Past, present and future
-
Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: past, present and future. Biochim Biophys Acta 2010;1800:760-9.
-
(2010)
Biochim Biophys Acta
, vol.1800
, pp. 760-769
-
-
Wang, W.1
Knovich, M.A.2
Coffman, L.G.3
Torti, F.M.4
Torti, S.V.5
-
18
-
-
13444252281
-
Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin
-
DOI 10.1073/pnas.0409409102
-
Knutson MD, Oukka M, Koss LM, Aydemir F, Wessling-Resnick M. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci U S A 2005; 102:1324-8. (Pubitemid 40209169)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.5
, pp. 1324-1328
-
-
Knutson, M.D.1
Oukka, M.2
Koss, L.M.3
Aydemir, F.4
Wessling-Resnick, M.5
-
20
-
-
0035896642
-
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
-
Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-10.
-
(2001)
J Biol Chem
, vol.276
, pp. 7806-7810
-
-
Park, C.H.1
Valore, E.V.2
Waring, A.J.3
Ganz, T.4
-
21
-
-
2342510407
-
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
-
DOI 10.1172/JCI200420945
-
Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-6. (Pubitemid 39069926)
-
(2004)
Journal of Clinical Investigation
, vol.113
, Issue.9
, pp. 1271-1276
-
-
Nemeth, E.1
Rivera, S.2
Gabayan, V.3
Keller, C.4
Taudorf, S.5
Pedersen, B.K.6
Ganz, T.7
-
22
-
-
51649096725
-
Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver
-
Kautz L, Meynard D, Monnier A, et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 2008;112:1503-9.
-
(2008)
Blood
, vol.112
, pp. 1503-1509
-
-
Kautz, L.1
Meynard, D.2
Monnier, A.3
-
23
-
-
34447137331
-
Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance
-
DOI 10.1172/JCI31342
-
Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest 2007;117:1933-9. (Pubitemid 47036327)
-
(2007)
Journal of Clinical Investigation
, vol.117
, Issue.7
, pp. 1933-1939
-
-
Babitt, J.L.1
Huang, F.W.2
Xia, Y.3
Sidis, Y.4
Andrews, N.C.5
Lin, H.Y.6
-
24
-
-
63449122819
-
Lack of the bone morphogenetic protein BMP6 induces massive iron overload
-
Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth MP. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 2009;41:478-81.
-
(2009)
Nat Genet
, vol.41
, pp. 478-481
-
-
Meynard, D.1
Kautz, L.2
Darnaud, V.3
Canonne-Hergaux, F.4
Coppin, H.5
Roth, M.P.6
-
25
-
-
63449103712
-
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
-
Andriopoulos B Jr, Corradini E, Xia Y, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 2009;41:482-7.
-
(2009)
Nat Genet
, vol.41
, pp. 482-487
-
-
Andriopoulos Jr., B.1
Corradini, E.2
Xia, Y.3
-
26
-
-
46749158788
-
Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin
-
Xia Y, Babitt JL, Sidis Y, Chung RT, Lin HY. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood 2008;111:5195-204.
-
(2008)
Blood
, vol.111
, pp. 5195-5204
-
-
Xia, Y.1
Babitt, J.L.2
Sidis, Y.3
Chung, R.T.4
Lin, H.Y.5
-
27
-
-
33644876815
-
A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
-
Wang RH, Li C, Xu X, et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2005;2:399-409.
-
(2005)
Cell Metab
, vol.2
, pp. 399-409
-
-
Wang, R.H.1
Li, C.2
Xu, X.3
-
28
-
-
23644460325
-
A mouse model of juvenile hemochromatosis
-
DOI 10.1172/JCI25049
-
Huang FW, Pinkus JL, Pinkus GS, Fleming MD, Andrews NC. A mouse model of juvenile hemochromatosis. J Clin Invest 2005;115:2187-91. (Pubitemid 41134160)
-
(2005)
Journal of Clinical Investigation
, vol.115
, Issue.8
, pp. 2187-2191
-
-
Huang, F.W.1
Pinkus, J.L.2
Pinkus, G.S.3
Fleming, M.D.4
Andrews, N.C.5
-
29
-
-
23644444316
-
Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload
-
DOI 10.1172/JCI25683
-
Niederkofler V, Salie R, Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest 2005;115:2180-6. (Pubitemid 41134159)
-
(2005)
Journal of Clinical Investigation
, vol.115
, Issue.8
, pp. 2180-2186
-
-
Niederkofler, V.1
Salie, R.2
Arber, S.3
-
30
-
-
33646370235
-
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
-
Babitt JL, Huang FW, Wrighting DM, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 2006;38:531-9.
-
(2006)
Nat Genet
, vol.38
, pp. 531-539
-
-
Babitt, J.L.1
Huang, F.W.2
Wrighting, D.M.3
-
31
-
-
39649115776
-
The Transferrin Receptor Modulates Hfe-Dependent Regulation of Hepcidin Expression
-
DOI 10.1016/j.cmet.2007.11.016, PII S1550413107003737
-
Schmidt PJ, Toran PT, Giannetti AM, Bjorkman PJ, Andrews NC. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab 2008;7:205-14. (Pubitemid 351285524)
-
(2008)
Cell Metabolism
, vol.7
, Issue.3
, pp. 205-214
-
-
Schmidt, P.J.1
Toran, P.T.2
Giannetti, A.M.3
Bjorkman, P.J.4
Andrews, N.C.5
-
32
-
-
33749393565
-
Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing
-
DOI 10.1074/jbc.C600197200
-
Goswami T, Andrews NC. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 2006;281: 28494-8. (Pubitemid 44506991)
-
(2006)
Journal of Biological Chemistry
, vol.281
, Issue.39
, pp. 28494-28498
-
-
Goswami, T.1
Andrews, N.C.2
-
33
-
-
0034610781
-
Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor
-
DOI 10.1038/47417
-
Bennett MJ, Lebrón JA, Bjorkman PJ. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Nature 2000;403:46-53. (Pubitemid 30038514)
-
(2000)
Nature
, vol.403
, Issue.6765
, pp. 46-53
-
-
Bennett, M.J.1
Lebron, J.A.2
Bjorkman, P.J.3
-
34
-
-
37549055467
-
HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1-HFE interactions
-
Chen J, Chloupková M, Gao J, Chapman- Arvedson TL, Enns CA. HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1-HFE interactions. J Biol Chem 2007;282:36862-70.
-
(2007)
J Biol Chem
, vol.282
, pp. 36862-36870
-
-
Chen, J.1
Chloupková, M.2
Gao, J.3
Chapman- Arvedson, T.L.4
Enns, C.A.5
-
35
-
-
60649103774
-
Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression
-
Gao J, Chen J, Kramer M, Tsukamoto H, Zhang AS, Enns CA. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab 2009;9:217-27.
-
(2009)
Cell Metab
, vol.9
, pp. 217-227
-
-
Gao, J.1
Chen, J.2
Kramer, M.3
Tsukamoto, H.4
Zhang, A.S.5
Enns, C.A.6
-
36
-
-
70350494274
-
BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression
-
Kautz L, Meynard D, Besson-Fournier C, et al. BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression. Blood 2009;114: 2515-20.
-
(2009)
Blood
, vol.114
, pp. 2515-2520
-
-
Kautz, L.1
Meynard, D.2
Besson-Fournier, C.3
-
37
-
-
70349494083
-
Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis
-
Corradini E, Garuti C, Montosi G, et al. Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis. Gastroenterology 2009;137:1489-97.
-
(2009)
Gastroenterology
, vol.137
, pp. 1489-1497
-
-
Corradini, E.1
Garuti, C.2
Montosi, G.3
-
38
-
-
78149271252
-
Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling: Implications for transferrin-dependent hepcidin regulation
-
Poli M, Luscieti S, Gandini V, et al. Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling: implications for transferrin-dependent hepcidin regulation. Haematologica 2010;95: 1832-40.
-
(2010)
Haematologica
, vol.95
, pp. 1832-1840
-
-
Poli, M.1
Luscieti, S.2
Gandini, V.3
-
39
-
-
73149083742
-
Combined deletion of HFE and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload
-
Wallace DF, Summerville L, Crampton EM, Frazer DM, Anderson GJ, Subramaniam VN. Combined deletion of HFE and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology 2009;50:1992- 2000.
-
(2009)
Hepatology
, vol.50
, pp. 1992-2000
-
-
Wallace, D.F.1
Summerville, L.2
Crampton, E.M.3
Frazer, D.M.4
Anderson, G.J.5
Subramaniam, V.N.6
-
40
-
-
34948904750
-
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
-
DOI 10.1038/nm1629, PII NM1629
-
Tanno T, Bhanu NV, Oneal PA, et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 2007;13:1096-101. (Pubitemid 47517510)
-
(2007)
Nature Medicine
, vol.13
, Issue.9
, pp. 1096-1101
-
-
Tanno, T.1
Bhanu, N.V.2
Oneal, P.A.3
Goh, S.-H.4
Staker, P.5
Lee, Y.T.6
Moroney, J.W.7
Reed, C.H.8
Luban, N.L.C.9
Wang, R.-H.10
Eling, T.E.11
Childs, R.12
Ganz, T.13
Leitman, S.F.14
Fucharoen, S.15
Miller, J.L.16
-
41
-
-
58149399349
-
Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I
-
Tamary H, Shalev H, Perez-Avraham G, et al. Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. Blood 2008;112:5241-4.
-
(2008)
Blood
, vol.112
, pp. 5241-5244
-
-
Tamary, H.1
Shalev, H.2
Perez-Avraham, G.3
-
42
-
-
80052430244
-
Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II
-
Berl
-
Casanovas G, Swinkels DW, Altamura S, et al. Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II. J Mol Med (Berl) 2011;89:811-6.
-
(2011)
J Mol Med
, vol.89
, pp. 811-816
-
-
Casanovas, G.1
Swinkels, D.W.2
Altamura, S.3
-
43
-
-
67651043722
-
Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells
-
Tanno T, Porayette P, Sripichai O, et al. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 2009;114:181-6.
-
(2009)
Blood
, vol.114
, pp. 181-186
-
-
Tanno, T.1
Porayette, P.2
Sripichai, O.3
-
44
-
-
78751598932
-
Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: New link between hypoxia signaling and iron homeostasis
-
Lakhal S, Schödel J, Townsend ARM, Pugh CW, Ratcliffe PJ, Mole DR. Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis. J Biol Chem 2011; 286:4090-7.
-
(2011)
J Biol Chem
, vol.286
, pp. 4090-4097
-
-
Lakhal, S.1
Schödel, J.2
Townsend, A.R.M.3
Pugh, C.W.4
Ratcliffe, P.J.5
Mole, D.R.6
-
45
-
-
56449096622
-
The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin
-
Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 2008; 8:502-11.
-
(2008)
Cell Metab
, vol.8
, pp. 502-511
-
-
Silvestri, L.1
Pagani, A.2
Nai, A.3
De Domenico, I.4
Kaplan, J.5
Camaschella, C.6
-
46
-
-
38349194098
-
Furin-mediated release of soluble hemojuvelin: A new link between hypoxia and iron homeostasis
-
Silvestri L, Pagani A, Camaschella C. Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 2008;111:924-31.
-
(2008)
Blood
, vol.111
, pp. 924-931
-
-
Silvestri, L.1
Pagani, A.2
Camaschella, C.3
-
47
-
-
75149190912
-
Iron homeostasis and its interaction with prolyl hydroxylases
-
Mole DR. Iron homeostasis and its interaction with prolyl hydroxylases. Antioxid Redox Signal 2010;12:445-58.
-
(2010)
Antioxid Redox Signal
, vol.12
, pp. 445-458
-
-
Mole, D.R.1
-
48
-
-
67651146945
-
HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis- related morbidity
-
Gurrin LC, Bertalli NA, Dalton GW, et al. HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis- related morbidity. Hepatology 2009;50: 94-101.
-
(2009)
Hepatology
, vol.50
, pp. 94-101
-
-
Gurrin, L.C.1
Bertalli, N.A.2
Dalton, G.W.3
-
49
-
-
0034022636
-
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
-
DOI 10.1038/75534
-
Camaschella C, Roetto A, Calì A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14-5. (Pubitemid 30257027)
-
(2000)
Nature Genetics
, vol.25
, Issue.1
, pp. 14-15
-
-
Camaschella, C.1
Roetto, A.2
Cali, A.3
De Gobbi, M.4
Garozzo, G.5
Carella, M.6
Majorano, N.7
Totaro, A.8
Gasparini, P.9
-
50
-
-
0035353167
-
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3
-
Roetto A, Totaro A, Piperno A, et al. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 2001;97:2555-60.
-
(2001)
Blood
, vol.97
, pp. 2555-2560
-
-
Roetto, A.1
Totaro, A.2
Piperno, A.3
-
51
-
-
9144252017
-
Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis
-
DOI 10.1038/ng1274
-
Papanikolaou G, Samuels ME, Ludwig EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004;36: 77-82. (Pubitemid 38056211)
-
(2004)
Nature Genetics
, vol.36
, Issue.1
, pp. 77-82
-
-
Papanikolaou, G.1
Samuels, M.E.2
Ludwig, E.H.3
MacDonald, M.L.E.4
Franchini, P.L.5
Dube, M.-P.6
Andres, L.7
MacFarlane, J.8
Sakellaropoulos, N.9
Politou, M.10
Nemeth, E.11
Thompson, J.12
Risler, J.K.13
Zaborowska, C.14
Babakaiff, R.15
Radomski, C.C.16
Pape, T.D.17
Davidas, O.18
Christakis, J.19
Brissot, P.20
Lockitch, G.21
Ganz, T.22
Hayden, M.R.23
Goldberg, Y.P.24
more..
-
52
-
-
20244388240
-
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
-
DOI 10.1038/ng1053
-
Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003;33:21-2. (Pubitemid 36068676)
-
(2003)
Nature Genetics
, vol.33
, Issue.1
, pp. 21-22
-
-
Roettol, A.1
Papanikolaou, G.2
Politou, M.3
Alberti, F.4
Girelli, D.5
Christakis, J.6
Loukopoulos, D.7
Camaschella, C.8
-
53
-
-
14944345916
-
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes
-
DOI 10.1053/j.gastro.2004.11.057
-
Pietrangelo A, Caleffi A, Henrion J, et al. Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes. Gastroenterology 2005; 128:470-9. (Pubitemid 40431098)
-
(2005)
Gastroenterology
, vol.128
, Issue.2
, pp. 470-479
-
-
Pietrangelo, A.1
Caleffi, A.2
Henrion, J.3
Ferrara, F.4
Corradini, E.5
Kulaksiz, H.6
Stremmel, W.7
Andreone, P.8
Garuti, C.9
-
54
-
-
32544437693
-
Iron overload due to mutations in ferroportin
-
De Domenico I, Ward DM, Musci G, Kaplan J. Iron overload due to mutations in ferroportin. Haematologica 2006;91:92-5. (Pubitemid 43235391)
-
(2006)
Haematologica
, vol.91
, Issue.1
, pp. 92-95
-
-
De Domenico, I.1
Ward, D.M.2
Musci, G.3
Kaplan, J.4
-
55
-
-
67651087324
-
The molecular basis of hepcidin-resistant hereditary hemochromatosis
-
Fernandes A, Preza GC, Phung Y, et al. The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 2009; 114:437-43.
-
(2009)
Blood
, vol.114
, pp. 437-443
-
-
Fernandes, A.1
Preza, G.C.2
Phung, Y.3
-
56
-
-
19544386871
-
Hepcidin in iron overload disorders
-
DOI 10.1182/blood-2004-12-4844
-
Papanikolaou G, Tzilianos M, Christakis JI, et al. Hepcidin in iron overload disorders. Blood 2005;105:4103-5. (Pubitemid 40656161)
-
(2005)
Blood
, vol.105
, Issue.10
, pp. 4103-4105
-
-
Papanikolaou, G.1
Tzilianos, M.2
Christakis, J.I.3
Bogdanos, D.4
Tsimirika, K.5
MacFarlane, J.6
Goldberg, Y.P.7
Sakellaropoulos, N.8
Ganz, T.9
Nemeth, E.10
-
57
-
-
33644873239
-
Ferroportin (Q248H) mutations in African families with dietary iron overload
-
DOI 10.1111/j.1440-1746.2005.03930.x
-
McNamara L, Gordeuk VR, MacPhail AP. Ferroportin (Q248H) mutations in African families with dietary iron overload. J Gastroenterol Hepatol 2005;20:1855-8. (Pubitemid 43961041)
-
(2005)
Journal of Gastroenterology and Hepatology
, vol.20
, Issue.12
, pp. 1855-1858
-
-
McNamara, L.1
Gordeuk, V.R.2
MacPhail, A.P.3
-
58
-
-
33745743014
-
Hepcidin and iron-loading anemias
-
Nemeth E, Ganz T. Hepcidin and iron-loading anemias. Haematologica 2006;91: 727-32. (Pubitemid 44014536)
-
(2006)
Haematologica
, vol.91
, Issue.6
, pp. 727-732
-
-
Nemeth, E.1
Ganz, T.2
-
59
-
-
78651378996
-
Iron-chelating therapy for transfusional iron overload
-
Brittenham GM. Iron-chelating therapy for transfusional iron overload. N Engl J Med 2011;364:146-56.
-
(2011)
N Engl J Med
, vol.364
, pp. 146-156
-
-
Brittenham, G.M.1
-
60
-
-
77955915545
-
Pathogenesis and management of iron toxicity in thalassemia
-
Hershko C. Pathogenesis and management of iron toxicity in thalassemia. Ann N Y Acad Sci 2010;1202:1-9.
-
(2010)
Ann N Y Acad Sci
, vol.1202
, pp. 1-9
-
-
Hershko, C.1
-
61
-
-
76349118307
-
Transferrin therapy ameliorates disease in beta-thalassemic mice
-
Li H, Rybicki AC, Suzuka SM, et al. Transferrin therapy ameliorates disease in beta-thalassemic mice. Nat Med 2010; 16:177-82.
-
(2010)
Nat Med
, vol.16
, pp. 177-182
-
-
Li, H.1
Rybicki, A.C.2
Suzuka, S.M.3
-
62
-
-
78649813036
-
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in beta-thalassemic mice
-
Gardenghi S, Ramos P, Marongiu MF, et al. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in beta-thalassemic mice. J Clin Invest 2010; 120:4466-77.
-
(2010)
J Clin Invest
, vol.120
, pp. 4466-4477
-
-
Gardenghi, S.1
Ramos, P.2
Marongiu, M.F.3
-
63
-
-
79959262524
-
Prospects for a hepcidin mimic to treat beta-thalassemia and hemochromatosis
-
Parrow NL, Gardenghi S, Rivella S. Prospects for a hepcidin mimic to treat beta-thalassemia and hemochromatosis. Expert Rev Hematol 2011;4:233-5.
-
(2011)
Expert Rev Hematol
, vol.4
, pp. 233-235
-
-
Parrow, N.L.1
Gardenghi, S.2
Rivella, S.3
-
64
-
-
0036799489
-
The genetics of inherited sideroblastic anemias
-
DOI 10.1053/shem.2002.35637
-
Fleming MD. The genetics of inherited sideroblastic anemias. Semin Hematol 2002;39:270-81. (Pubitemid 35192640)
-
(2002)
Seminars in Hematology
, vol.39
, Issue.4
, pp. 270-281
-
-
Fleming, M.D.1
-
66
-
-
39749126765
-
Iron overload in myelodysplastic syndromes
-
DOI 10.1080/10428190701843221, PII 790366266
-
Mahesh S, Ginzburg Y, Verma A. Iron overload in myelodysplastic syndromes. Leuk Lymphoma 2008;49:427-38. (Pubitemid 351298326)
-
(2008)
Leukemia and Lymphoma
, vol.49
, Issue.3
, pp. 427-438
-
-
Mahesh, S.1
Ginzburg, Y.2
Verma, A.3
-
67
-
-
0034585942
-
Biochemical and genetic defects underlying human congenital hypotransferrinemia
-
Goldwurm S, Casati C, Venturi N, et al. Biochemical and genetic defects underlying human congenital hypotransferrinemia. Hematol J 2000;1:390-8.
-
(2000)
Hematol J
, vol.1
, pp. 390-398
-
-
Goldwurm, S.1
Casati, C.2
Venturi, N.3
-
68
-
-
36348972935
-
Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia
-
DOI 10.3324/haematol.11377
-
Trombini P, Coliva T, Nemeth E, et al. Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia. Haematologica 2007;92: 1407-10. (Pubitemid 350144159)
-
(2007)
Haematologica
, vol.92
, Issue.10
, pp. 1407-1410
-
-
Trombini, P.1
Coliva, T.2
Nemeth, E.3
Mariani, R.4
Ganz, T.5
Biondi, A.6
Piperno, A.7
-
69
-
-
78751558997
-
Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice
-
Bartnikas TB, Andrews NC, Fleming MD. Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice. Blood 2011;117:630-7.
-
(2011)
Blood
, vol.117
, pp. 630-637
-
-
Bartnikas, T.B.1
Andrews, N.C.2
Fleming, M.D.3
-
70
-
-
0031981976
-
Aceruloplasminemia: An inherited neurodegenerative disease with impairment of iron homeostasis
-
Harris ZL, Klomp LW, Gitlin JD. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr 1998;67:5 Suppl:972S-977S. (Pubitemid 28198819)
-
(1998)
American Journal of Clinical Nutrition
, vol.67
, Issue.5 SUPPL.
-
-
Harris, Z.L.1
Klomp, L.W.J.2
Gitlin, J.D.3
-
71
-
-
68149168175
-
Not all DMT1 mutations lead to iron overload
-
Blanco E, Kannengiesser C, Grandchamp B, Tasso M, Beaumont C. Not all DMT1 mutations lead to iron overload. Blood Cells Mol Dis 2009;43:199-201.
-
(2009)
Blood Cells Mol Dis
, vol.43
, pp. 199-201
-
-
Blanco, E.1
Kannengiesser, C.2
Grandchamp, B.3
Tasso, M.4
Beaumont, C.5
-
72
-
-
0034795445
-
Neonatal hemochromatosis
-
DOI 10.1542/peds.108.4.960
-
Murray KF, Kowdley KV. Neonatal hemochromatosis. Pediatrics 2001;108: 960-4. (Pubitemid 32947667)
-
(2001)
Pediatrics
, vol.108
, Issue.4
, pp. 960-964
-
-
Murray, K.F.1
Kowdley, K.V.2
-
73
-
-
34548127283
-
Neonatal hemochromatosis: A congenital alloimmune hepatitis
-
DOI 10.1055/s-2007-985069
-
Whitington PF. Neonatal hemochromatosis: a congenital alloimmune hepatitis. Semin Liver Dis 2007;27:243-50. (Pubitemid 47301764)
-
(2007)
Seminars in Liver Disease
, vol.27
, Issue.3
, pp. 243-250
-
-
Whitington, P.F.1
-
74
-
-
70249151112
-
Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin
-
Rand EB, Karpen SJ, Kelly S, et al. Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin. J Pediatr 2009;155: 566-71.
-
(2009)
J Pediatr
, vol.155
, pp. 566-571
-
-
Rand, E.B.1
Karpen, S.J.2
Kelly, S.3
-
75
-
-
7644235252
-
High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis
-
DOI 10.1016/S0140-6736(04)17356-X, PII S014067360417356X
-
Whitington PF, Hibbard JU. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 2004;364:1690-8. (Pubitemid 39458145)
-
(2004)
Lancet
, vol.364
, Issue.9446
, pp. 1690-1698
-
-
Whitington, P.F.1
Hibbard, J.U.2
-
76
-
-
79958032358
-
Deoxyguanosine kinase deficiency presenting as neonatal hemochromatosis
-
Hanchard NA, Shchelochkov OA, Roy A, et al. Deoxyguanosine kinase deficiency presenting as neonatal hemochromatosis. Mol Genet Metab 2011;103:262-7.
-
(2011)
Mol Genet Metab
, vol.103
, pp. 262-267
-
-
Hanchard, N.A.1
Shchelochkov, O.A.2
Roy, A.3
-
77
-
-
2342435003
-
Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration
-
DOI 10.1002/mds.10650
-
Thomas M, Hayflick SJ, Jankovic J. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Mov Disord 2004;19:36-42. (Pubitemid 38559618)
-
(2004)
Movement Disorders
, vol.19
, Issue.1
, pp. 36-42
-
-
Thomas, M.1
Hayflick, S.J.2
Jankovic, J.3
-
78
-
-
79954460490
-
Childhood disorders of neurodegeneration with brain iron accumulation (NBIA)
-
Kurian MA, McNeill A, Lin JP, Maher ER. Childhood disorders of neurodegeneration with brain iron accumulation (NBIA). Dev Med Child Neurol 2011;53: 394-404.
-
(2011)
Dev Med Child Neurol
, vol.53
, pp. 394-404
-
-
Kurian, M.A.1
McNeill, A.2
Lin, J.P.3
Maher, E.R.4
-
79
-
-
0034935036
-
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome
-
DOI 10.1038/ng572
-
Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001;28:345-9. (Pubitemid 32702423)
-
(2001)
Nature Genetics
, vol.28
, Issue.4
, pp. 345-349
-
-
Zhou, B.1
Westaway, S.K.2
Levinson, B.3
Johnson, M.A.4
Gitschier, J.5
Hayflick, S.J.6
-
80
-
-
0037413484
-
Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome
-
DOI 10.1056/NEJMoa020817
-
Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003;348:33-40. (Pubitemid 36026344)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.1
, pp. 33-40
-
-
Hayflick, S.J.1
Westaway, S.K.2
Levinson, B.3
Zhou, B.4
Johnson, M.A.5
Ching, K.H.L.6
Gitschier, J.7
-
81
-
-
0034941118
-
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease
-
DOI 10.1038/ng571
-
Curtis ARJ, Fey C, Morris CM, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001;28:350-4. (Pubitemid 32702424)
-
(2001)
Nature Genetics
, vol.28
, Issue.4
, pp. 350-354
-
-
Curtis, A.R.J.1
Fey, C.2
Morris, C.M.3
Bindoff, L.A.4
Ince, P.G.5
Chinnery, P.F.6
Coulthard, A.7
Jackson, M.J.8
Jackson, A.P.9
McHale, D.P.10
Hay, D.11
Barker, W.A.12
Markham, A.F.13
Bates, D.14
Curtis, A.15
Burn, J.16
-
82
-
-
33750709690
-
Brain Iron Metabolism
-
DOI 10.1016/j.spen.2006.08.002, PII S107190910600101X
-
Rouault TA, Cooperman S. Brain iron metabolism. Semin Pediatr Neurol 2006; 13:142-8. (Pubitemid 44709651)
-
(2006)
Seminars in Pediatric Neurology
, vol.13
, Issue.3
, pp. 142-148
-
-
Rouault, T.A.1
Cooperman, S.2
-
83
-
-
43049150678
-
Metals in Alzheimer's and Parkinson's diseases
-
Barnham KJ, Bush AI. Metals in Alzheimer's and Parkinson's diseases. Curr Opin Chem Biol 2008;12:222-8.
-
(2008)
Curr Opin Chem Biol
, vol.12
, pp. 222-228
-
-
Barnham, K.J.1
Bush, A.I.2
-
84
-
-
0035122450
-
Frataxin: Its role in iron metabolism and the pathogenesis of Friedreich's ataxia
-
DOI 10.1016/S1357-2725(00)00067-4, PII S1357272500000674
-
Becker E, Richardson DR. Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia. Int J Biochem Cell Biol 2001;33:1-10. (Pubitemid 32146462)
-
(2001)
International Journal of Biochemistry and Cell Biology
, vol.33
, Issue.1
, pp. 1-10
-
-
Becker, E.1
Richardson, D.R.2
-
85
-
-
77954627973
-
Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol
-
Richardson DR, Lane DJ, Becker EM, et al. Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci U S A 2010;107:10775-82.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 10775-10782
-
-
Richardson, D.R.1
Lane, D.J.2
Becker, E.M.3
-
86
-
-
0035138072
-
Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits
-
DOI 10.1038/84818
-
Puccio H, Simon D, Cossée M, et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 2001;27:181-6. (Pubitemid 32157445)
-
(2001)
Nature Genetics
, vol.27
, Issue.2
, pp. 181-186
-
-
Puccio, H.1
Simon, D.2
Cossee, M.3
Criqui-Filipe, P.4
Tiziano, F.5
Melki, J.6
Hindelang, C.7
Matyas, R.8
Rustin, P.9
Koenig, M.10
-
87
-
-
85045841958
-
Hemochromatosis and vitamin C
-
Herbert V. Hemochromatosis and vitamin C. Ann Intern Med 1999;131:475-6.
-
(1999)
Ann Intern Med
, vol.131
, pp. 475-476
-
-
Herbert, V.1
-
88
-
-
80051800854
-
IRon overload screeNing tool (IRON): Development of a tool to guide screening in primary care
-
Mainous AG III, Diaz VA, Everett CJ, et al. IRon overload screeNing tool (IRON): development of a tool to guide screening in primary care. Am J Hematol 2011;86: 733-7.
-
(2011)
Am J Hematol
, vol.86
, pp. 733-737
-
-
Mainous III, A.G.1
Diaz, V.A.2
Everett, C.J.3
-
89
-
-
0037326566
-
Hemochromatosis and iron overload screening (HEIRS) Study design for an evaluation of 100,000 primary care-based adults
-
DOI 10.1097/00000441-200302000-00001
-
McLaren CE, Barton JC, Adams PC, et al. Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary carebased adults. Am J Med Sci 2003;325:53-62. (Pubitemid 36236661)
-
(2003)
American Journal of the Medical Sciences
, vol.325
, Issue.2
, pp. 53-62
-
-
McLaren, C.E.1
Barton, J.C.2
Adams, P.C.3
Harris, E.L.4
Acton, R.T.5
Press, N.6
Reboussin, D.M.7
McLaren, G.D.8
Sholinsky, P.9
Walker, A.P.10
Gordeuk, V.R.11
Leiendecker-Foster, C.12
Dawkins, F.W.13
Eckfeldt, J.H.14
Mellen, B.G.15
Speechley, M.16
Thomson, E.17
-
90
-
-
63449115492
-
Ferritin for the clinician
-
Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev 2009;23:95-104.
-
(2009)
Blood Rev
, vol.23
, pp. 95-104
-
-
Knovich, M.A.1
Storey, J.A.2
Coffman, L.G.3
Torti, S.V.4
Torti, F.M.5
-
91
-
-
62949152341
-
Towards explaining "unexplained hyperferritinemia."
-
Camaschella C, Poggiali E. Towards explaining "unexplained hyperferritinemia." Haematologica 2009;94:307-9.
-
(2009)
Haematologica
, vol.94
, pp. 307-309
-
-
Camaschella, C.1
Poggiali, E.2
-
92
-
-
0034964604
-
A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload
-
DOI 10.1086/321261
-
Kato J, Fujikawa K, Kanda M, et al. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet 2001;69:191-7. (Pubitemid 32614030)
-
(2001)
American Journal of Human Genetics
, vol.69
, Issue.1
, pp. 191-197
-
-
Kato, J.1
Fujikawa, K.2
Kanda, M.3
Fukuda, N.4
Sasaki, K.5
Takayama, T.6
Kobune, M.7
Takada, K.8
Takimoto, R.9
Hamada, H.10
Ikeda, T.11
Niitsu, Y.12
-
95
-
-
0033564146
-
HFE genotype in patients with hemochromatosis and other liver diseases
-
Bacon BR, Olynyk JK, Brunt EM, Britton RS, Wolff RK. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999;130:953-62. (Pubitemid 29283985)
-
(1999)
Annals of Internal Medicine
, vol.130
, Issue.12
, pp. 953-962
-
-
Bacon, B.R.1
Olynyk, J.K.2
Brunt, E.M.3
Britton, R.S.4
Wolff, R.K.5
-
96
-
-
73949096220
-
Iron overload: Consequences, assessment, and monitoring
-
Taher AT, Musallam KM, Inati A. Iron overload: consequences, assessment, and monitoring. Hemoglobin 2009;33:Suppl 1: S46-S47.
-
(2009)
Hemoglobin
, vol.33
, Issue.SUPPL. 1
-
-
Taher, A.T.1
Musallam, K.M.2
Inati, A.3
-
97
-
-
0014465766
-
Alteration in cobalt absorption in patients with disorders of iron metabolism
-
Valberg LS, Ludwig J, Olatunbosun D. Alteration in cobalt absorption in patients with disorders of iron metabolism. Gastroenterology 1969;56:241-51.
-
(1969)
Gastroenterology
, vol.56
, pp. 241-251
-
-
Valberg, L.S.1
Ludwig, J.2
Olatunbosun, D.3
-
98
-
-
0014056175
-
Liver manganese in hemochromatosis
-
Altstatt LB, Pollack S, Feldman MH, Reba RC, Crosby WH. Liver manganese in hemochromatosis. Proc Soc Exp Biol Med 1967;124:353-5.
-
(1967)
Proc Soc Exp Biol Med
, vol.124
, pp. 353-355
-
-
Altstatt, L.B.1
Pollack, S.2
Feldman, M.H.3
Reba, R.C.4
Crosby, W.H.5
-
99
-
-
0028484522
-
Blood lead concentrations in hereditary hemochromatosis
-
Barton JC, Patton MA, Edwards CQ, et al. Blood lead concentrations in hereditary hemochromatosis. J Lab Clin Med 1994;124:193-8. (Pubitemid 2134311)
-
(1994)
Journal of Laboratory and Clinical Medicine
, vol.124
, Issue.2
, pp. 193-198
-
-
Barton, J.C.1
Patton, M.A.2
Edwards, C.Q.3
Griffen, L.M.4
Kushner, J.P.5
Meeks, R.G.6
Leggett, R.W.7
-
100
-
-
24744458603
-
Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs
-
DOI 10.1182/blood-2005-04-1766
-
Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin- containing organs. Blood 2005; 106:2196-9. (Pubitemid 41291740)
-
(2005)
Blood
, vol.106
, Issue.6
, pp. 2196-2199
-
-
Rivera, S.1
Nemeth, E.2
Gabayan, V.3
Lopez, M.A.4
Farshidi, D.5
Ganz, T.6
-
101
-
-
29744463634
-
Exploring the role of hepcidin, an antimicrobial and iron regulatory peptide, in increased iron absorption in beta-thalassemia
-
DOI 10.1196/annals.1345.069
-
Breda L, Gardenghi S, Guy E, et al. Exploring the role of hepcidin, an antimicrobial and iron regulatory peptide, in increased iron absorption in beta-thalassemia. Ann N Y Acad Sci 2005;1054:417-22. (Pubitemid 43031049)
-
(2005)
Annals of the New York Academy of Sciences
, vol.1054
, pp. 417-422
-
-
Breda, L.1
Gardenghi, S.2
Guy, E.3
Rachmilewitz, E.A.4
Weizer-Stern, O.5
Adamsky, K.6
Amariglio, N.7
Rechavi, G.8
Giardina, P.J.9
Grady, R.W.10
Rivella, S.11
-
102
-
-
78649634981
-
Hepcidin in human iron disorders: Therapeutic implications
-
Pietrangelo A. Hepcidin in human iron disorders: therapeutic implications. J Hepatol 2011;54:173-81.
-
(2011)
J Hepatol
, vol.54
, pp. 173-181
-
-
Pietrangelo, A.1
|